|By Marketwired .||
|July 16, 2014 04:15 PM EDT||
LONDON, ONTARIO -- (Marketwired) -- 07/16/14 -- Critical Outcome Technologies Inc. (COTI) (TSX VENTURE:COT)(OTCQB:COTQF) announced today that it is amending the expiry date of 3,569,458 common share purchase warrants (Warrants) issued as part of a non-brokered private placement on January 30, 2013, that were scheduled to expire on July 29, 2014. Each Warrant entitled its holder to purchase one common share of the Company at an exercise price of $0.26 per share for a period of 18 months from the date of issue.
"This amendment recognizes the potential future financing source represented by these warrants at a relatively low cost to the Company," said Dr. Wayne Danter, President and Chief Executive Officer. "The amendment also acknowledges the long term support of these investors in various private placements."
The expiry date is being extended to 5:00 p.m. (Toronto time) on January 29, 2016, (the New Expiry Date), provided that the New Expiry Date of the Warrants will be accelerated to 21 days if, for any ten consecutive trading days, the closing price of the common shares equals or exceeds $0.60. All other terms and conditions of the Warrants remain unchanged.
The Company will deliver a Notice of Amendment reflecting the amended expiry date to the registered holders of the Warrants.
About Critical Outcome Technologies Inc. (COTI)
COTI is a leading-edge bioinformatics company specializing in accelerating the discovery and development of small molecules - dramatically reducing the time and cost to bring new drugs to market. COTI's proprietary artificial intelligence system, CHEMSAS®, utilizes a series of predictive computer models to identify compounds with a high probability of being successfully developed from disease specific drug discovery through chemical optimization and preclinical testing. These compounds are targeted for a variety of diseases, particularly those for which current treatments are either lacking or ineffective.
For more information, visit www.criticaloutcome.com.
Follow @CriticalOutcome on Twitter at http://twitter.com/CriticalOutcome.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Sep. 27, 2016 10:45 PM EDT Reads: 3,380
Sep. 27, 2016 10:45 PM EDT Reads: 2,836
Sep. 27, 2016 10:30 PM EDT Reads: 2,172
Sep. 27, 2016 09:30 PM EDT Reads: 2,958
Sep. 27, 2016 09:30 PM EDT Reads: 475
Sep. 27, 2016 08:30 PM EDT Reads: 2,038
Sep. 27, 2016 08:15 PM EDT Reads: 2,233
Sep. 27, 2016 07:00 PM EDT Reads: 2,860
Sep. 27, 2016 06:45 PM EDT Reads: 1,819
Sep. 27, 2016 06:30 PM EDT Reads: 3,568
Sep. 27, 2016 06:30 PM EDT Reads: 2,207
Sep. 27, 2016 06:15 PM EDT Reads: 413
Sep. 27, 2016 06:00 PM EDT Reads: 1,701
Sep. 27, 2016 05:45 PM EDT Reads: 1,666
So, you bought into the current machine learning craze and went on to collect millions/billions of records from this promising new data source. Now, what do you do with them? Too often, the abundance of data quickly turns into an abundance of problems. How do you extract that "magic essence" from your data without falling into the common pitfalls? In her session at @ThingsExpo, Natalia Ponomareva, Software Engineer at Google, provided tips on how to be successful in large scale machine learning...
Sep. 27, 2016 05:30 PM EDT Reads: 2,036